Abiopharma

Amphastar Announces FDA Approval for Iron Sucrose Injection, USP

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

Greenwich LifeSciences Provides Update on CEO Interviews & Corporate Events

General Announcement: CHANGES IN SUBSTANTIAL SHAREHOLDERS INTEREST PURSUANT TO SECTION 138 OF THE COMPANIES ACT 2016

Kexing Biopharm Enters Strategic Partnership with IQVIA to Accelerate Global Expansion

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

FDA approve FENOFIBRATE

FDA approve ERIBULIN MESYLATE

Form 7 Monthly Progress Report July 2025

Press Release – BioMark Diagnostics Announces Expansion of its Specialty Laboratory Services in Quebec to Accommodate Increased Demand from International Partnerships

Press Release – BioMark Diagnostics Highlights Fiscal Year 2025 Achievements and Sets Bold Strategic Milestones for 2025 – 2026

RxSight, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - RXST

Smith+Nephew PLC Notification

Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease